MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects…
ROVER: ELAROS delivers an industrial visit to University of Florence ELAROS Director of Research and Development, Román Rocha Lawrence, delivered a two week industrial visit to the Università degli Studi…
MammoScreen holds its first in person consortium meeting On the 17th and 18th of May, ELAROS had the exciting opportunity to attend the first MammoScreen Consortium Meeting at London Southbank…
Mi-Trial Launches Innovative New Clinical Trials App And Portal To Improve Trial Participation And Outcomes Mi-Trial, a new company which has developed an innovative clinical trial companion system and app,…
ELAROS Appoints Scientific Director for New Innovate UK Project ELAROS is delighted to announce that Dr Thomas Richards will join the team from the 1st April 2022, in the new…
ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS is delighted to be able to announce that we…
C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients ELAROS is pleased to announce on behalf of our C19-YRS clinical partners the first global study…
ELAROS to kick-off Innovate UK project centred around urology ELAROS is pleased to kick-off an Innovate UK project today to further the development of our innovative Digital Bladder Diary; a…
ELAROS Signs New Partnership Deal with The University of West London to Deliver Improved Hydration for Older People The University of West London (UWL) signs new partnership deal with ELAROS…
ELAROS to Sponsor Asthma Research Ph.D Studentship ELAROS is pleased to announce its sponsorship of a Ph.D studentship in collaboration with the University of Sheffield, the Sheffield Pulmonary Vascular Disease…